Bone Biologics (BBLG) P/E (2016 - 2026)
Bone Biologics (BBLG) P/E from Mar 31, 2016 to Jul 21, 2026. The TTM Bone Biologics (BBLG) P/E is -0.70. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Bone Biologics (BBLG)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.70 | +48.59% |
| 2025 | -0.47 | -61.21% |
| 2024 | -1.22 | -72.92% |
| 2023 | -4.51 | -95.89% |
| 2022 | -109.69 | -94.04% |
| 2021 | -1.84K | -51.47% |
| 2020 | -3.79K | +269.60% |
| 2019 | -1.03K | -50.61% |
| 2018 | -2.08K | +97.03% |
| 2017 | -1.05K | -43.75% |
| 2016 | -1.88K | N/A |
Comparison Bone Biologics (BBLG) P/E with competitors
Bone Biologics (BBLG) P/E is -0.70.